Startups chasing an eventual acquisition are increasingly optimising for the wrong scoreboard, according to the exit data coming out of 2026, and the gap between what founders track internally and what buyers actually pay for is widening.

Health Management Solutions is the most active exit cluster with 60 deals, ahead of Patient Solutions, Medical Diagnostics and Population Health Management, per Galen Growth's tracking.

Across the dataset, the median last funding round before an M&A exit confirms acquirers are buying the underlying asset and its customer contracts, not covering a company's ongoing cash burn. Galen Growth's analysis is blunt about which startups are misreading the market: those still optimising for user acquisition over engagement depth, pilot contracts over recurring revenue, or clinical publications over payer agreements are, in the report's own words, misallocating resources against a market that has moved on.

That framing matters because it applies across clusters, not just the leading one. Even in Medical Diagnostics and Population Health Management, the smaller clusters by deal count, the same underlying pattern holds: acquirers are consistently rewarding contracted, recurring revenue over headline user growth.

This is a direct extension of the "proof over vision" shift showing up elsewhere in this issue, from Medicare's outcome-aligned reimbursement models to the measurement-based care standard now expected in mental health and women's health.

Startups building toward these metrics early are simply better positioned whenever an acquisition conversation eventually starts, whether that's in six months or three years, because the underlying evidence base doesn't need to be built from scratch under deal pressure.

Audit your own startup's core metrics against this list now, not when a buyer shows up. If your growth story leans on total users or pilot logos rather than contracted revenue and outcome data, that is worth fixing well before any exit conversation begins.

Also watch which exit cluster grows fastest next quarter, since that tends to signal where acquirer appetite is shifting before it shows up in headline deal announcements. A cluster that's quietly growing its deal count, even without one headline mega-deal, is often a better leading indicator than a single large transaction elsewhere in the market.